NOTA:FRA
ნოვარტისი
136,00 €
arrow_upward
+0,74%(+1,00) 1D
21 ოქტ, 08:49:52 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOTA...
Open
136,00 €
High
136,00 €
Low
136,00 €
Mkt. cap
257,73 მლრ.
Avg. vol.
30,00
Volume
0,00
52-wk high
145,00 €
52-wk low
102,50 €
No. of employees
75 ათ.
Open
136,00 €
High
136,00 €
Low
136,00 €
Mkt. cap
257,73 მლრ.
Avg. vol.
30,00
Volume
0,00
52-wk high
145,00 €
52-wk low
102,50 €
No. of employees
75 ათ.
News stories
From web sources and news partners
AD HOC NEWS
·
52 წუთის წინ
Novartis stock has investor call on October 23 ahead of Xetra open
ad-hoc-news.de
·
23 საათის წინ
Novartis wins FDA approval as Novartis stock stands at EUR 135.15
ad-hoc-news.de
·
1 დღის წინ
Novartis stock: October 23 investor call ahead of the Xetra open
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About ნოვარტისი
CEOვასანტ ნარასიმჰანი
Employees75,3 ათ.
Founded7 მარ. 1996
Headquartersბაზელი, ბაზელ-შტადტის კანტონი, შვეიცარია
SectorPharmaceutical industry
Websitenovartis.com